Menu

Post image 1
Post image 2
Post image 3
Post image 4
Post image 5
Post image 6
Post image 7
Post image 8
Post image 9
1 / 9
0

Watch Wegovy Weight-Loss Pill: Novo CEO Says No Intention to Lower Prices Further - Bloomberg

Bloomberg·Bloomberg·27 days ago
#ACaRG7r9
#that#wegovy#doustdar#2026novo#says#intention
Reading 0:00
15s threshold

May 6th, 2026

Novo CEO Says No Intention to Lower Wegovy Prices Further

Novo Nordisk CEO Mike Doustdar discusses the drugmaker's Wegovy obesity pill which fueled sales in the first quarter. Novo is "very optimistic" on the medication despite competition from Eli Lilly, Doustdar tells Bloomberg Television, and the firm doesn't anticipate any price reductions.

Read More